Sean Liu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. (NCT05181709) | Sean Liu | 2022-02-09 |
Track Sean Liu automatically
Every clearance here is in the API, with alerts when new ones post.